Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: Results of a controlled study of etilefrine versus placebo
- 27 January 1995
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 25 (1) , 65-69
- https://doi.org/10.1016/0735-1097(94)00336-o
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Usefulness of Fluoxetine Hydrochloride for Prevention of Resistant Upright Tilt Induced SyncopePacing and Clinical Electrophysiology, 1993
- Methodology of isoproterenol-tilt table testing in patients with syncopeJournal of the American College of Cardiology, 1992
- Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncopeJournal of the American College of Cardiology, 1992
- Methodology of head-up tilt testing in patients with unexplained syncopeJournal of the American College of Cardiology, 1991
- Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardiaThe American Journal of Cardiology, 1990
- Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic studyThe American Journal of Cardiology, 1990
- The head-up tilt table test in patients with syncope of unknown originAmerican Heart Journal, 1989
- Provocation of Bradycardia and Hypotension by Isoproterenol and Upright Posture in Patients with Unexplained SyncopeNew England Journal of Medicine, 1989
- Upright Body Tilt for Evaluation of Patients With Recurrent, Unexplained SyncopePacing and Clinical Electrophysiology, 1989
- HEAD-UP TILT: A USEFUL TEST FOR INVESTIGATING UNEXPLAINED SYNCOPEThe Lancet, 1986